Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Silesian Center for Heart Diseases, Zabrze, Poland.
Med Sci Monit. 2010 Feb;16(2):CR67-74.
The prevalence of diabetes mellitus (DM) and chronic kidney disease (CKD) is rapidly increasing. Both comorbidities are considered significant risk factors for cardiovascular complications. The aim of the study was to evaluate the impact of DM with and without CKD on prognosis in patients with acute myocardial infarction (AMI) treated invasively.
MATERIAL/METHODS: This single-center prospective study encompassed 3334 AMI-patients without cardiogenic shock, who were divided into 2 major groups: 999 patients with type 2 DM diagnosed prior to or during index hospitalization, and 2335 non-diabetics. All diabetic patients were divided with respect to their renal status into: diabetics with CKD (DM-CKD; n=264) and without (DM-nCKD; n=735). Short- and long-term outcomes were compared between study groups. Independent predictors of death and composite end-point were selected with multivariate Cox-regression model.
Mortality rates were significantly higher in DM group compared to nDM in all observation periods. DM-CKD was associated with excessive total mortality (35.6%) when compared to DM-nCKD (11.6%, P<0.001) and to nDM (9.8%, P<0.001). Mortality and major adverse cardiovascular event rates did not differ significantly between DM-nCKD and nDM groups. Diabetes coexisting with CKD was one of the strongest independent risk factors for death (hazard ratio 1.93; confidence interval 1.79-2.07; P<0.001).
The prognosis in diabetics with AMI is significantly related to renal function. Diabetics without CKD had similar prognosis to non-diabetics. Multivariate analyses showed that unlike diabetes without renal dysfunction, DM-CKD was an independent risk factor for cardiovascular complications and total mortality.
糖尿病(DM)和慢性肾脏病(CKD)的患病率正在迅速上升。这两种合并症都被认为是心血管并发症的重要危险因素。本研究的目的是评估合并或不合并 CKD 的糖尿病对接受介入治疗的急性心肌梗死(AMI)患者预后的影响。
材料/方法:这项单中心前瞻性研究纳入了 3334 名无心源性休克的 AMI 患者,将其分为 2 个主要组:999 名在指数住院期间或之前诊断为 2 型糖尿病的患者和 2335 名非糖尿病患者。所有糖尿病患者均根据其肾脏状况分为:合并 CKD 的糖尿病患者(DM-CKD;n=264)和不合并 CKD 的糖尿病患者(DM-nCKD;n=735)。比较研究组之间的短期和长期结局。使用多变量 Cox 回归模型选择死亡和复合终点的独立预测因素。
DM 组的死亡率在所有观察期均明显高于 nDM 组。与 DM-nCKD(11.6%,P<0.001)和 nDM(9.8%,P<0.001)相比,DM-CKD 与过高的总死亡率相关(35.6%)。DM-nCKD 组和 nDM 组之间的死亡率和主要不良心血管事件发生率无显著差异。合并 CKD 的糖尿病是死亡的最强独立危险因素之一(危险比 1.93;置信区间 1.79-2.07;P<0.001)。
患有 AMI 的糖尿病患者的预后与肾功能显著相关。无 CKD 的糖尿病患者的预后与非糖尿病患者相似。多变量分析显示,与无肾功能障碍的糖尿病不同,DM-CKD 是心血管并发症和总死亡率的独立危险因素。